Analysis of a membrane-enriched proteome from postmortem human brain tissue in Alzheimer's disease (original) (raw)
Semiquantitative proteomic analysis of human hippocampal tissues from Alzheimer’s disease and age-matched control brains
Jochen Deckert
Clinical Proteomics, 2013
View PDFchevron_right
Qualitative Proteomics Analysis of Proteins and Biomarkers of Alzheimer’ Disease
Aneela Ashraf
ASEAN Journal of Science and Engineering, 2022
View PDFchevron_right
Proteomic analysis of cerebrospinal fluid in Alzheimer's disease: wanted dead or alive
Magdolna Pákáski, Miklós Sántha
Journal of Alzheimer's disease : JAD, 2015
View PDFchevron_right
Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease
Indira Pla
Neurobiology of Disease, 2019
View PDFchevron_right
Proteomic Biomarkers in Alzheimer's disease
Ramón Cacabelos
Diagnostic Pathology: Open Access, 2016
View PDFchevron_right
Alzheimer disease pathology and the cerebrospinal fluid proteome
Hugues Henry
Alzheimer's Research & Therapy
View PDFchevron_right
Proteome-based plasma biomarkers for Alzheimer's disease
M. Ward, FrÜhling Rijsdijk
Brain, 2006
View PDFchevron_right
Label-Free Quantitative LC–MS Proteomics of Alzheimer’s Disease and Normally Aged Human Brains
Victor Andreev
Journal of Proteome Research, 2012
View PDFchevron_right
Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration
alessandra castegna
Journal of Neurochemistry, 2003
View PDFchevron_right
Biological Significance of the Protein Changes Occurring in the Cerebrospinal Fluid of Alzheimer’s Disease Patients: Getting Clues from Proteomic Studies
Francisco Alcain
Diagnostics
View PDFchevron_right
Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer’s Disease Pathology in Older Adults
Hugues Henry
Journal of Alzheimer's Disease
View PDFchevron_right
Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer's Disease
Abhay Moghekar
PROTEOMICS – Clinical Applications, 2018
View PDFchevron_right
From proteomics to biomarker discovery in Alzheimer's disease
Laurel Blackman
Brain Research Reviews, 2005
View PDFchevron_right
Quantitative proteomic analysis of the frontal cortex in Alzheimer’s disease
Abhay Moghekar
Journal of Neurochemistry, 2020
View PDFchevron_right
Use of proteomic methods in the analysis of human body fluids in Alzheimer research
Petra Zürbig
ELECTROPHORESIS, 2012
View PDFchevron_right
Targeted human cerebrospinal fluid proteomics for the validation of multiple Alzheimer's disease biomarker candidates
Shuyu Hou
Journal of Chromatography B, 2013
View PDFchevron_right
Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease
Lucia Sue
Alzheimer's & Dementia, 2010
View PDFchevron_right
Proteomic Analysis of Alzheimers Disease Cerebrospinal Fluid from Neuropathologically Diagnosed Subjects
Lucia Sue
Current Alzheimer Research, 2009
View PDFchevron_right
Insights into the changes in the proteome of Alzheimer disease elucidated by a meta-analysis
Sophia Schedin Weiss
Scientific Data, 2021
View PDFchevron_right
Changes in the plasma proteome at asymptomatic and symptomatic stages of autosomal dominant Alzheimer’s disease
Anbupalam Thalamuthu
Scientific Reports, 2016
View PDFchevron_right
Blood-Based Proteomic Profiling Identifies Potential Biomarker Candidates and Pathogenic Pathways in Dementia
Julie Decock
International Journal of Molecular Sciences
View PDFchevron_right
Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression
James Lah
Proteomics, 2016
View PDFchevron_right
Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease
Niels Andreasen
Molecular Brain Research, 2003
View PDFchevron_right
Proteomic Changes in Cerebrospinal Fluid of Presymptomatic and Affected Persons Carrying Familial Alzheimer Disease Mutations
Yuchen Bai
Archives of Neurology, 2012
View PDFchevron_right
High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer's Disease in Human Cerebrospinal Fluid
Andy Liaw
PloS one, 2015
View PDFchevron_right